BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18490865)

  • 1. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
    Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of Carraguard vaginal gel use among Thai couples.
    Whitehead SJ; Kilmarx PH; Blanchard K; Manopaiboon C; Chaikummao S; Friedland B; Achalapong J; Wankrairoj M; Mock P; Thanprasertsuk S; Tappero JW
    AIDS; 2006 Nov; 20(17):2141-8. PubMed ID: 17086053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
    Marais D; Gawarecki D; Allan B; Ahmed K; Altini L; Cassim N; Gopolang F; Hoffman M; Ramjee G; Williamson AL
    Antivir Ther; 2011; 16(8):1219-26. PubMed ID: 22155903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial.
    Kilmarx PH; van de Wijgert JH; Chaikummao S; Jones HE; Limpakarnjanarat K; Friedland BA; Karon JM; Manopaiboon C; Srivirojana N; Yanpaisarn S; Supawitkul S; Young NL; Mock PA; Blanchard K; Mastro TD
    J Acquir Immune Defic Syndr; 2006 Nov; 43(3):327-34. PubMed ID: 16980907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carraguard acceptability among men and women in a couples study in Thailand.
    Martin S; Blanchard K; Manopaiboon C; Chaikummao S; Schaffer K; Friedland B; Kilmarx PH
    J Womens Health (Larchmt); 2010 Aug; 19(8):1561-7. PubMed ID: 20575712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Giguere JF; Domingo MC; Piret J; Tsague L; Zekeng L; Mwatha A; Mâsse B; Bergeron MG
    Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
    AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL; Hart CW
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
    Jespers V; Buvé A; Van Damme L
    Sex Transm Dis; 2007 Jul; 34(7):519-22. PubMed ID: 17297382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
    Doh AS; Ngoh N; Roddy R; Lai JJ; Linton K; Mauck C
    Contraception; 2007 Sep; 76(3):245-9. PubMed ID: 17707724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.
    Carraguard Phase II South Africa Study Team
    Contraception; 2010 Dec; 82(6):563-71. PubMed ID: 21074021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
    Whitehead SJ; McLean C; Chaikummao S; Braunstein S; Utaivoravit W; van de Wijgert JH; Mock PA; Siraprapasiri T; Friedland BA; Kilmarx PH; Markowitz LE
    PLoS One; 2011; 6(9):e14831. PubMed ID: 21915249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.
    van der Straten A; Napierala S; Cheng H; Mauck C; Depineres T; Dhlakama P; Thompson M; Chipato T; Hammond N; Padian N
    Contraception; 2007 Nov; 76(5):389-99. PubMed ID: 17963865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand.
    McLean CA; van de Wijgert JH; Jones HE; Karon JM; McNicoll JM; Whitehead SJ; Braunstein S; Achalapong J; Chaikummao S; Tappero JW; Markowitz LE; Kilmarx PH
    AIDS; 2010 Mar; 24(5):717-22. PubMed ID: 20098295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of a carrageenan-based candidate vaginal microbicide and matching placebo: findings from a phase II safety trial among women in Chiang Rai, Thailand.
    Jones HE; Chaikummao S; van de Wijgert JH; Friedland BA; Manopaiboon C; Witwatwongwana P; Wankrairot M; Chantharojwong N; Kilmarx PH
    J Womens Health (Larchmt); 2009 Jul; 18(7):1003-10. PubMed ID: 19575689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fourteen-day safety and acceptability study of the universal placebo gel.
    Schwartz JL; Ballagh SA; Kwok C; Mauck CK; Weiner DH; Rencher WF; Callahan MM
    Contraception; 2007 Feb; 75(2):136-41. PubMed ID: 17241844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
    Joglekar NS; Joshi SN; Deshpande SS; Parkhe AN; Katti UR; Mehendale SM
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
    Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
    J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
    Frezieres RG; Walsh T; Kilbourne-Brook M; Coffey PS
    Contraception; 2012 Jan; 85(1):99-107. PubMed ID: 22067809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.